Elligo Health Research, Inc.
Elligo Health Research, Inc., headquartered in the United States, is a pioneering force in the clinical research industry. Founded in 2016, the company has rapidly established itself as a leader in enhancing patient access to clinical trials, particularly through its innovative approach to integrating research into healthcare settings. With a focus on patient-centric solutions, Elligo offers a unique platform that streamlines the clinical trial process, making it more efficient and accessible for both patients and sponsors. Their core services include site management, patient recruitment, and data analytics, all designed to optimise trial outcomes. Recognised for its commitment to improving healthcare delivery, Elligo Health Research has achieved significant milestones, positioning itself as a trusted partner in advancing medical research and development.
DitchCarbon Score
How does Elligo Health Research, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elligo Health Research, Inc.'s score of 3 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Elligo Health Research, Inc.'s reported carbon emissions
Elligo Health Research, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive sustainability strategy. In the context of the industry, many organisations are increasingly focusing on establishing measurable climate goals and reducing their environmental impact. As such, it would be beneficial for Elligo Health Research to consider setting clear targets and reporting on their emissions to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elligo Health Research, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
